Lanxess in talks buy Belgium-based Taminco $ 1.4 billion

Lanxess in talks to buy Belgium-based Taminco for $ 1.4 billion

3:53 PM, 8th June 2011
Lanxess in talks to buy Belgium-based Taminco for $ 1.4 billion

FRANKFURT, GERMANY: Lanxess is in talks to buy Belgian chemicals group Taminco from private equity firm CVC for about  € 1 billion ($ 1.4 billion), the Financial Times Deutschland reported.

The acquisition would be the largest in Lanxess’ history, the paper said in an advance copy of its Wednesday edition, citing financial and sector sources. Lanxess and Taminco declined to comment. CVC was not immediately available for comment.

The German group had said earlier this month that acquisitions of targets with up to 1 billion euros in sales were possible. Taminco had sales of  € 715 million in 2010.

Lanxess is being advised by JP Morgan and the sellers by Goldman Sachs and Merrill Lynch, the paper said.

 © Thomson Reuters 2011

 

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Chemtura sees demand for petroleum additives

PHILADELPHIA, US: Chemtura Corporation has announced the pending completion of the next stage of its multi-stage capacity increase plan for its line ...

Read more
Samsung Fine Chemicals and MEMC joint venture for polysilicon

SEOUL, SOUTH KOREA/ST PETERS, US: Samsung Fine Chemicals (SFC) and MEMC Electronic Materials Inc announced a joint venture agreement between SFC and ...

Read more
LANXESS’s price adjustment for engineering plastics

LEVERKUSEN, GERMANY: LANXESS AG is to increase its prices for Durethan Compounds (Polyamide Compounds, PA) and Pocan Compounds (Polybutylenterephtha ...

Read more
NOVA Chemicals strengthen business leadership

PITTSBURGH, US: To strengthen its market focus strategy and create sustainable leadership, NOVA Chemicals has made some business leadership announce ...

Read more
Genzyme sells Pharmaceuticals Business to ICIG

CAMBRIDGE, US: Genzyme Corporation has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group (IC ...

Read more
Dow to pay down $1.5 billion in debt

MIDLAND, US: The Dow Chemical Company recently said that it is launching a cash tender offer for approximately $ 750 million aggregate principal amo ...

Read more